US 12364737
Activin receptor type IIA variants and methods of use thereof
granted A61KA61K38/179A61P
Quick answer
US patent 12364737 (Activin receptor type IIA variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/179, A61P, A61P35/00, A61P7/06